查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1676836

受託研究機構服務市場按類型、測試類型、治療領域和最終用戶分類 - 2025 年至 2030 年全球預測

Contract Research Organizations Services Market by Type, Testing Type, Therapeutic Area, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

受託研究機構服務市場預計將從 2024 年的 774.2 億美元成長到 2025 年的 857.2 億美元，複合年成長率為 10.92%，到 2030 年達到 1,442 億美元。

主要市場統計數據
基準年 2024 年 774.2億美元
預計 2025 年 857.2億美元
預測年份 2030 1,442億美元
複合年成長率（%） 10.92％

在當今充滿活力的醫療保健和製藥環境中，委外研發機構(CRO) 是致力於創新和高效將產品推向市場的公司的重要合作夥伴。近年來，在突破性科學發現、監管變化和技術快速進步的推動下，該行業經歷了重大變革。這種轉變將 CRO 的角色從單純的服務提供者提升為策略合作者，旨在克服發展障礙和管理複雜的多學科計劃。

數位資料管理和自動化實驗室流程等先進方法的整合現在使 CRO 能夠簡化業務、縮短交付時間並提高整體研究品質。相關人員現在面臨著包括成本壓力、緩慢的病患招募和嚴格的監管要求等挑戰。採用尖端技術和強大的分析能力將使公司在臨床研究和開發中實現更高的效率。

在這種競爭格局中，CRO 的價值提案因其提供專業知識和敏捷營運模式的能力而凸顯。這一介紹觀點為深入探討轉型轉變、細微細分以及精準的區域和公司分析如何重塑產業奠定了基礎。隨著市場動態的不斷發展，決策者發現全面的洞察力對於指南策略性投資、最佳化資源配置和利用新的商業機會變得更加重要。

重新定義合約研究格局的變革

在過去十年中，一系列變革改變了研究外包格局，改變了服務的交付方式和相關人員的價值感知方式。現代 CRO 不再只是服務提供者；他們是深度參與臨床試驗設計和執行的策略合作夥伴，利用數位工具和進階分析來推動更好的結果。這種對技術整合的新重視是當前轉型的根本催化劑。

從歷史上看，該行業的特點是採用傳統的、孤立的研究服務方式。然而，隨著先進的數位平台、資料管理系統和人工智慧的出現，自動化和即時資料分析正在共同推動進步。這些發展提高了效率，改善了法規遵循並縮短了時間表。公司正在採取積極主動的態度，同時應對可擴展性、成本最佳化和複雜的試驗管理等挑戰。

此外，不斷變化的監管要求以及客戶和患者不斷提高的期望要求重新評估研究方案和調查方法。人們需要更細粒度的資料流和整合不同資訊來源的能力。這種變化不僅是技術性的，也是策略性的，因為產業領導者重新調整其業務框架和經營模式以保持競爭力。現代臨床研究的協作性質，加上整合的供應鏈，意味著從發現到臨床前到臨床服務的所有要素都是相互關聯的，從而推動每個階段的創新。

推動市場動態的關鍵細分洞察

全面了解市場細分對於識別成長機會和策略定位起著關鍵作用。市場研究基於臨床研究服務、諮詢服務、資料管理服務、市場開發、化驗服務和臨床前服務等服務類型。早期開發進一步細分為專注於化學、製造和控制、發現研究和臨床前服務的專業部門，而實驗室服務也分為特定的子類別，如分析測試和生物分析測試。這種分層方法加深了對服務提供多樣化的理解。

同時，基於測試類型的分析強調了體外和體內測試的重要性。評估這些研究模式可以為 CRO 範圍內的方法偏好和性能優勢提供重要的見解。此外，按治療領域細分可以揭示面臨的疾病和病症的市場，例如循環系統疾病、中樞神經系統疾病、皮膚病感染疾病、消化器官系統、傳染病、腫瘤學、眼科學等。這些治療領域推動了產業內的研究重點和資源分配。

此外，基於最終用戶的市場區隔也正在獲得顯著發展動能。學術和研究機構、農業化學品和農藥公司、生技公司、政府機構和製藥公司各自都有獨特的需求和期望。透過分析這些基本要素，相關人員能夠根據每個群體的具體需求制定策略，從而提高參與度和更有效的市場滲透率。

目錄

第 1 章 簡介

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 藥物開發過程日益複雜
      • 醫藥研發投入快速增加
      • 研究活動中越來越多採用外包服務
    • 限制因素
      • 對臨床試驗過程中資料安全和病患隱私的擔憂
    • 機會
      • 專注於先進細胞和基因治療的新型臨床試驗設計和通訊協定
      • CRO實施的數位化與敏捷製造/研發技術
    • 任務
      • 臨床研究中的患者招募和保留問題。
  • 市場區隔分析
    • 類型：專注於臨床前服務中的新化合物發現
    • 最終用戶：生技公司擴大使用 CRO 服務
  • 波特五力分析
  • PESTEL 分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

第6章受託研究機構服務市場按類型

  • 臨床研究服務
  • 諮詢服務
  • 資料管理服務
  • 早期開發服務
    • 化學、製造和控制
    • 探索研究
    • 臨床前服務
  • 化驗服務
    • 分析測試
    • 生物分析測試
  • 臨床前服務

第7章受託研究機構服務市場按測試類型

  • 體外測試
  • 體內測試

第8章受託研究機構服務市場按治療領域

  • 心血管疾病
  • 中樞神經系統疾病
  • 皮膚科
  • 消化系統疾病
  • 感染疾病
  • 腫瘤學
  • 眼科

第9章受託研究機構服務市場依最終用戶分類

  • 學術研究所
  • 農業化學品和殺蟲劑公司
  • 生技公司
  • 政府
  • 製藥公司

10. 美洲受託研究機構服務市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

11. 亞太受託研究機構服務市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

12. 歐洲、中東和非洲受託研究機構服務市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章 競爭格局

  • 2024 年市場佔有率分析
  • FPNV 定位矩陣，2024 年
  • 競爭情境分析
  • 戰略分析與建議

公司列表

  • Advanced Clinical LLC
  • Alcanza Clinical Research, LLC.
  • Almac Group LIMITED
  • CELERION, INC.
  • Charles River Laboratories International, Inc.
  • CLINTEC INTERNATIONAL PRIVATE LIMITED
  • dMedClinical Co. Ltd.
  • Envigo, Inc.
  • Ergomed Plc
  • Eurofins Scientific SE
  • ICON plc
  • IQVIA Private Limited
  • KCR SA
  • LabCorp Laboratory Corporation
  • Linical Co.,Ltd.
  • Medpace Holdings, Inc.
  • Novotech Clinical Research India Private Limited
  • Parexel International（MA）Corporation
  • PPD Inc. by Thermo Fisher Scientific Inc.
  • Premier Research Group Limited
  • PSI CRO AG
  • Quotient Sciences Limited
  • SGS SA
  • SIGNANT HEALTH LIMITED
  • Syneos Health Inc.
  • TFS International AB
  • Veristat, LLC
  • Worldwide Clinical Trials Holdings, Inc.
  • WuXi AppTec Co., Ltd.
Product Code: MRR-EF0BD2D82C3B

The Contract Research Organizations Services Market was valued at USD 77.42 billion in 2024 and is projected to grow to USD 85.72 billion in 2025, with a CAGR of 10.92%, reaching USD 144.20 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 77.42 billion
Estimated Year [2025] USD 85.72 billion
Forecast Year [2030] USD 144.20 billion
CAGR (%) 10.92%

In today's dynamic healthcare and pharmaceutical environment, contract research organizations (CROs) serve as pivotal partners for companies striving to innovate and bring products to market efficiently. The industry has seen substantial evolution over recent years, driven by groundbreaking scientific discoveries, regulatory changes, and a rapid pace of technological advancement. This transformation enhances the role of CROs from simple service providers to strategic collaborators intended to overcome developmental hurdles and manage complex, multidisciplinary projects.

The integration of advanced methodologies, including digital data management and automated laboratory processes, has allowed CROs to streamline operations, reduce turnaround times, and increase overall research quality. Stakeholders are now better positioned to face challenges such as cost pressures, patient recruitment delays, and stringent regulatory demands. With the incorporation of cutting-edge technologies and robust analytics, organizations are empowered to achieve higher efficiency levels in their clinical research and development endeavors.

Throughout this competitive landscape, the value proposition of CROs is underscored by their ability to offer specialized expertise coupled with agile operational models. This introductory outlook sets the stage for a deeper dive into how transformative shifts, nuanced segmentation, and precise regional and corporate analyses are reshaping the industry. As market dynamics continue to evolve, decision-makers find themselves more reliant on comprehensive insights to guide strategic investments, optimize resource allocation, and capitalize on emerging business opportunities.

Transformative Shifts Redefining the Contract Research Landscape

The contract research landscape has been shaped by a series of transformative shifts over the past decade, revolutionizing the way services are delivered and how stakeholders perceive value. Modern CROs are no longer just service executors; they are strategic partners deeply involved in the design and implementation of clinical trials, leveraging digital tools and sophisticated analytics to drive better outcomes. This newfound emphasis on technology integration is one of the fundamental catalysts behind the current transformation.

Historically, the industry was characterized by traditional, siloed approaches to research services. However, with the advent of advanced digital platforms, data management systems, and artificial intelligence, there is now a concerted push towards automation and real-time data analysis. These developments have given rise to enhanced efficiencies, improved regulatory compliance, and accelerated timelines. Companies are increasingly adopting a proactive stance, concurrently addressing the challenges of scalability, cost optimization, and complex trial management.

Furthermore, evolving regulatory mandates and heightened expectations from both clients and patients have necessitated a re-evaluation of research protocols and testing methodologies. Emphasis has shifted towards patient-centric models and precision medicine, demanding more detailed data streams and our ability to integrate diverse sources of information. The change is not merely technical but also strategic, as industry leaders realign their operational frameworks and business models to remain competitive. The collaborative nature of modern clinical research, coupled with an integrated supply chain, ensures that every component from discovery through to preclinical and clinical services is interconnected, fostering innovation at every step.

Key Segmentation Insights Driving Market Dynamics

A comprehensive understanding of market segmentation plays a critical role in identifying key opportunities for growth and strategic positioning. The market is studied based on service types that encompass clinical research services, consulting services, data management services, early phase development, laboratory services, and preclinical services. Within early phase development, further breakdown occurs through specialized divisions focusing on chemistry, manufacturing and control, discovery studies, and preclinical services, while laboratory services also branch into specific subcategories such as analytical testing alongside bioanalytical testing. This layered approach provides depth in understanding the diversification of service offerings.

In parallel, analysis based on testing types highlights the importance of both in-vitro and in-vivo testing. Evaluating these testing modalities yields critical insights into methodological preferences and performance advantages across the spectrum of CRO activities. Moreover, segmentation by therapeutic areas illuminates markets challenged by diseases and conditions such as cardiovascular diseases, central nervous system disorders, dermatology, gastrointestinal ailments, infectious diseases, oncology, and ophthalmology. These therapeutic focuses drive research priorities and resource allocation within the industry.

Additionally, the market's segmentation based on end-users is gaining crucial momentum. Academic and research institutes, agrochemical and pesticide companies, biotechnology companies, government organizations, and pharmaceutical companies each bring unique demands and expectations. Analyzing these components enables stakeholders to tailor strategies that resonate with the specific requirements of each group, thus fostering improved engagement and more effective market penetration.

Based on Type, market is studied across Clinical Research Services, Consulting Services, Data Management Services, Early Phase Development Services, Laboratory Services, and Preclinical Services. The Early Phase Development Services is further studied across Chemistry, Manufacturing & Control, Discovery Studies, and Preclinical Services. The Laboratory Services is further studied across Analytical Testing and Bioanalytical Testing.

Based on Testing Type, market is studied across In-Vitro Testing and In-Vivo Testing.

Based on Therapeutic Area, market is studied across Cardiovascular Diseases, Central Nervous System Disorders, Dermatology, Gastrointestinal Diseases, Infectious Diseases, Oncology, and Ophthalmology.

Based on End-User, market is studied across Academic & Research Institutes, Agrochemical & Pesticide Companies, Biotechnology Companies, Government Organizations, and Pharmaceutical Companies.

Critical Regional Insights Shaping Global Opportunities

A nuanced regional analysis underlines the certainty that geographic diversity influences market opportunities and competitive landscapes. In the Americas, the mature market displays robust investment in research infrastructure combined with evolving regulatory reforms that promote innovation and collaboration. Meanwhile, the combined region of Europe, Middle East & Africa offers a mix of highly developed research hubs alongside emerging growth markets where regulatory harmonization is streamlining processes and enabling access to international clinical trials. Most notably, the Asia-Pacific region has been rapidly expanding owing to ongoing governmental initiatives, increasing investment in healthcare infrastructure, and rising demand for innovative therapies.

This interplay between established economies and emerging markets is critical for stakeholders seeking to identify priority areas for growth. Embracing regional diversity not only offers potential for improved access to capital, but also incentivizes the adoption of cutting-edge technologies and best practices that could be replicated across other markets. As a result, understanding these regional trends and developing localized strategies is fundamental to maintaining competitive advantage in a globally interconnected environment.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

In-Depth Company Insights Unveiling Industry Leaders

Evaluating key players in the market furnishes a vivid picture of competitive dynamics and operational excellence within the industry. The landscape includes companies such as Advanced Clinical LLC, Alcanza Clinical Research, LLC., and Almac Group LIMITED, each recognized for their robust service portfolios and innovative approaches. Equally important are organizations like CELERION, INC. and Charles River Laboratories International, Inc., which have consistently set benchmarks in reliability and quality. Continued success is also seen with firms such as CLINTEC INTERNATIONAL PRIVATE LIMITED, dMedClinical Co. Ltd., and Envigo, Inc. - all demonstrating agility in adapting to evolving market demands.

Other notable contributors include Ergomed Plc, Eurofins Scientific SE, ICON plc, and IQVIA Private Limited. Their commitment to integrating advanced technological solutions with traditional research paradigms has paved the way for streamlined clinical trial processes. Often, companies such as KCR S.A., LabCorp Laboratory Corporation, Linical Co.,Ltd., Medpace Holdings, Inc., and Novotech Clinical Research India Private Limited have gained reputations for timely project delivery and comprehensive end-to-end solutions. Market leaders like Parexel International (MA) Corporation, PPD Inc. by Thermo Fisher Scientific Inc., Premier Research Group Limited, PSI CRO AG, Quotient Sciences Limited, SGS SA, SIGNANT HEALTH LIMITED, Syneos Health Inc., TFS International AB, Veristat, LLC, Worldwide Clinical Trials Holdings, Inc., and WuXi AppTec Co., Ltd. have also contributed significantly by fostering innovation and best practices across varied research disciplines.

These companies not only reflect the competitive intensity of the market but also serve as benchmark drivers whose strategic decisions and operational efficiencies impact the broader industry landscape. Their ongoing initiatives highlight the pressing need for agility, thought leadership, and robust research capabilities in today's fast-evolving clinical research environment.

The report delves into recent significant developments in the Contract Research Organizations Services Market, highlighting leading vendors and their innovative profiles. These include Advanced Clinical LLC, Alcanza Clinical Research, LLC., Almac Group LIMITED, CELERION, INC., Charles River Laboratories International, Inc., CLINTEC INTERNATIONAL PRIVATE LIMITED, dMedClinical Co. Ltd., Envigo, Inc., Ergomed Plc, Eurofins Scientific SE, ICON plc, IQVIA Private Limited, KCR S.A., LabCorp Laboratory Corporation, Linical Co.,Ltd., Medpace Holdings, Inc., Novotech Clinical Research India Private Limited, Parexel International (MA) Corporation, PPD Inc. by Thermo Fisher Scientific Inc., Premier Research Group Limited, PSI CRO AG, Quotient Sciences Limited, SGS SA, SIGNANT HEALTH LIMITED, Syneos Health Inc., TFS International AB, Veristat, LLC, Worldwide Clinical Trials Holdings, Inc., and WuXi AppTec Co., Ltd.. Actionable Recommendations for Forward-Thinking Industry Leaders

To thrive amidst the rapidly evolving research landscape, industry leaders are advised to adopt a multi-faceted strategy built on innovation, efficiency, and collaboration. Leaders should focus on investing in advanced digital tools that streamline data acquisition and analysis, ultimately reducing the turnaround times for essential clinical projects. Diversification in service portfolios, with a keen understanding of both traditional and emerging therapeutic areas, is essential to meet the rising demands of diverse end-user segments. Continuing to integrate state-of-the-art automation and technological solutions will ensure that operations remain scalable and efficient in a competitive market.

It is imperative to nurture strategic partnerships that leverage global expertise and local market knowledge, thereby mitigating risks associated with regional regulatory complexities. Additionally, refining methodologies to incorporate both in-vitro and in-vivo testing is crucial for fine-tuning research outcomes. Leaders should emphasize not only meeting current market standards but consistently evolving to set new benchmarks for quality and innovation. Investing in training and upskilling teams and integrating comprehensive risk management strategies will further contribute to sustainable growth and improved operational efficiency.

Adopting a proactive market strategy that anticipates shifts in therapeutic priorities and patient-centric research trends will provide a strategic edge. In doing so, industry leaders stand well-prepared to capitalize on emerging opportunities while simultaneously mitigating potential market disruptions.

Conclusion: Navigating a Complex and Dynamic Market Environment

In conclusion, the contract research industry is experiencing an era of profound transformation driven by rapid technological advancement, evolving regulatory norms, and diversification in service and customer needs. The strategic segmentation based on research services, testing types, therapeutic areas, and end-user requirements highlights a complex yet opportunity-rich environment. Regional insights underscore the importance of understanding local market dynamics, while key company evaluations reveal the capabilities and strategic prowess that drive industry standards. As stakeholders continue to grapple with a fast-evolving ecosystem, there is a compelling argument for proactive adaptation, strategic investments, and collaborative synergies to secure sustained success in the years ahead.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing complexity of drug development processes
      • 5.1.1.2. Surge in investments in pharmaceutical research and development
      • 5.1.1.3. Rise in adoption of outsourced services for research activities
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns over data security and patient privacy in clinical trial processes
    • 5.1.3. Opportunities
      • 5.1.3.1. Emphasis on novel clinical trial designs and protocols for more advanced cell and gene therapy
      • 5.1.3.2. Adoption of digitized and agile manufacturing and research development techniques by CROs
    • 5.1.4. Challenges
      • 5.1.4.1. Issues of patient recruitment and retention for clinical research
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing emphasis on discovery studies to identify new compounds in preclinical services
    • 5.2.2. End User: Expanding utilization of CRO services by biotechnology firms
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Contract Research Organizations Services Market, by Type

  • 6.1. Introduction
  • 6.2. Clinical Research Services
  • 6.3. Consulting Services
  • 6.4. Data Management Services
  • 6.5. Early Phase Development Services
    • 6.5.1. Chemistry, Manufacturing & Control
    • 6.5.2. Discovery Studies
    • 6.5.3. Preclinical Services
  • 6.6. Laboratory Services
    • 6.6.1. Analytical Testing
    • 6.6.2. Bioanalytical Testing
  • 6.7. Preclinical Services

7. Contract Research Organizations Services Market, by Testing Type

  • 7.1. Introduction
  • 7.2. In-Vitro Testing
  • 7.3. In-Vivo Testing

8. Contract Research Organizations Services Market, by Therapeutic Area

  • 8.1. Introduction
  • 8.2. Cardiovascular Diseases
  • 8.3. Central Nervous System Disorders
  • 8.4. Dermatology
  • 8.5. Gastrointestinal Diseases
  • 8.6. Infectious Diseases
  • 8.7. Oncology
  • 8.8. Ophthalmology

9. Contract Research Organizations Services Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Agrochemical & Pesticide Companies
  • 9.4. Biotechnology Companies
  • 9.5. Government Organizations
  • 9.6. Pharmaceutical Companies

10. Americas Contract Research Organizations Services Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Contract Research Organizations Services Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Contract Research Organizations Services Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. FPNV Positioning Matrix, 2024
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Strategic partnership between Novotech and Biostar enhances clinical research innovations
    • 13.3.2. Novotech enhances early-phase biotech trials expertise with new strategic delivery unit
    • 13.3.3. Parexel and Palantir partner to enhance clinical trials with AI-driven innovations
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advanced Clinical LLC
  • 2. Alcanza Clinical Research, LLC.
  • 3. Almac Group LIMITED
  • 4. CELERION, INC.
  • 5. Charles River Laboratories International, Inc.
  • 6. CLINTEC INTERNATIONAL PRIVATE LIMITED
  • 7. dMedClinical Co. Ltd.
  • 8. Envigo, Inc.
  • 9. Ergomed Plc
  • 10. Eurofins Scientific SE
  • 11. ICON plc
  • 12. IQVIA Private Limited
  • 13. KCR S.A.
  • 14. LabCorp Laboratory Corporation
  • 15. Linical Co.,Ltd.
  • 16. Medpace Holdings, Inc.
  • 17. Novotech Clinical Research India Private Limited
  • 18. Parexel International (MA) Corporation
  • 19. PPD Inc. by Thermo Fisher Scientific Inc.
  • 20. Premier Research Group Limited
  • 21. PSI CRO AG
  • 22. Quotient Sciences Limited
  • 23. SGS SA
  • 24. SIGNANT HEALTH LIMITED
  • 25. Syneos Health Inc.
  • 26. TFS International AB
  • 27. Veristat, LLC
  • 28. Worldwide Clinical Trials Holdings, Inc.
  • 29. WuXi AppTec Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET MULTI-CURRENCY
  • FIGURE 2. CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET MULTI-LANGUAGE
  • FIGURE 3. CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET RESEARCH PROCESS
  • FIGURE 4. CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 17. AMERICAS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 19. UNITED STATES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 25. CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY DATA MANAGEMENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY CHEMISTRY, MANUFACTURING & CONTROL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY DISCOVERY STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY ANALYTICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY IN-VITRO TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY IN-VIVO TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY AGROCHEMICAL & PESTICIDE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY GOVERNMENT ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 116. MALAYSIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. MALAYSIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 118. MALAYSIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 122. PHILIPPINES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 124. PHILIPPINES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 128. SINGAPORE CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SINGAPORE CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 130. SINGAPORE CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH KOREA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 136. SOUTH KOREA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 140. TAIWAN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. TAIWAN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 142. TAIWAN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 146. THAILAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. THAILAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 148. THAILAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 152. VIETNAM CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. VIETNAM CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 154. VIETNAM CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 165. DENMARK CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. DENMARK CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 167. DENMARK CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 170. EGYPT CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 171. EGYPT CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. EGYPT CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 173. EGYPT CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 176. FINLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 177. FINLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. FINLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 179. FINLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 182. FRANCE CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 183. FRANCE CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. FRANCE CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 185. FRANCE CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 188. GERMANY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 189. GERMANY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. GERMANY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 191. GERMANY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 194. ISRAEL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 195. ISRAEL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. ISRAEL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 197. ISRAEL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 200. ITALY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 201. ITALY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. ITALY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 203. ITALY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 206. NETHERLANDS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. NETHERLANDS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 212. NIGERIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 213. NIGERIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. NIGERIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 215. NIGERIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 218. NORWAY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 219. NORWAY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. NORWAY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 221. NORWAY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 224. POLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 225. POLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. POLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 227. POLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 230. QATAR CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 231. QATAR CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. QATAR CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 233. QATAR CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 236. RUSSIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 237. RUSSIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. RUSSIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 239. RUSSIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 242. SAUDI ARABIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. SAUDI ARABIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 254. SPAIN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 255. SPAIN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. SPAIN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 257. SPAIN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 260. SWEDEN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 261. SWEDEN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. SWEDEN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 263. SWEDEN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 266. SWITZERLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. SWITZERLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 272. TURKEY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 273. TURKEY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. TURKEY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 275. TURKEY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES CONTRACT RE